SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MANALTO LIMITED (MTL)

Suspended from ASX

SHARE PRICES

Former (or subsequent) names

 FROMTO
MANALTO LIMITED18/03/2015
HEALTHLINX LIMITED16/03/200618/03/2015
CRYPTOME PHARMACEUTICALS LIMITED16/03/2006

Shareholder links

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MTL5
Address: Regal Gardens, 249 Annangrove Road, Annangrove, NSW
Tel:  +61 8 6555 2950 Fax: +61 8 6166 0261

Date first listed: 06/11/2003
Company Secretary: Brendan Brown
Sector: Software & Services Industry Group: XIJ
Activities: Developing novel, non-invasive, serum-based, diagnostic products and a platform for generating therapeutic and nutraceutical peptide leads

The company has entered into a term sheet with Hoozu, a leading Australian Social Media and IT company. It is proposed that the organisations will collaborate in social media marketing and enhanced software development via a joint venture.

31/08/2020

Shareholders in this company should consider crystallising a capital loss in 2020/21 by selling their worthless shares, which they can achieve online by entering transaction details here. While this usually makes good economic sense, we recommend you seek professional advice before buying or selling securities, your accountant is probably the best person.

13/08/2020

The company lodges its Appendix 4C - quarterly.

31/01/2020

The company lodges its Quarterly Activities Report.

31/01/2020

The company has signed an agreement for services with Shi Hai Dong Tian today. Shi Hai Dong Tian is the company's first mainland Chinese client and the Board of Manalto warmly welcome the opportunity to work closely together. The initial contract secures payment of A$20,000 per month to the company.

15/01/2020

The company releases the results of its meeting.

27/11/2019

The company lodges its Quarterly Activities Report.

31/10/2019

The company lodges its Appendix 4C - quarterly.

31/10/2019

The company's AGM will be held at 10:00 AM (WST) on 27 November 2019 at Suite 1, 295 Rokeby Road, Subiaco WA 6008.

25/10/2019

MTL's securities will remain suspended until further notice under Listing Rule 17.3 as ASX has determined that MTL's operations and financial condition are not adequate to warrant the continued quotation of its securities and therefore it is in breach of Listing Rules 12.1 and 12.2. The suspension will continue until MTL is able to demonstrate compliance with Listing Rules 12.1 and 12.2.

18/10/2019

MTL has earlier today lodged its FY2019 Report. However, MTL securities will remain suspended until further notice pending the outcome of enquiries in relation to the FY2019 Report and its compliance with Listing Rule 12.2.

11/10/2019

The company releases its Appendix 4G.

11/10/2019

The company releases its Corporate Governance Statement.

11/10/2019

The company lodges its Annual Report to shareholders.

11/10/2019

The company has entered into an unsecured loan of $400,000 from an unrelated private lender, Mr David Mullan, for the purposes of funding ongoing working capital requirements. Key terms are as follows: Repayment: 12 months from the date of execution repayable in cash; Interest: 4% of the loan amount, convertible into MTL shares subject to shareholder approval if required; Security: the loan is unsecured; Repayment: 12 months from the date of execution.

08/10/2019

The company has received commitments of A$163,000 to be completed as a private placement to a sophisticated and professional investor, Mr Qi Cao. The placement will be completed by the issue of 546,358,294 fully paid ordinary shares at $0.0003 per share. Funds raised under this will be used for working capital purposes.

04/10/2019

The company's securities will be suspended from Official Quotation in accordance with Listing Rule 17.5 from the commencement of trading today, 1 October 2019, following failure to lodge the relevant periodic report by the due date.

01/10/2019

The suspension of trading in the securities of Manalto Limited will be lifted from the commencement of trading today, Friday, 8 March 2019, following the release of MTL's Half Year Financial Report on 7 March 2019.

08/03/2019

The securities of Manalto Limited will be reinstated to Official Quotation as from the commencement of trading on Friday, 8 March 2019 following lodgement of its Half Year Financial Report for the period ended 31 December 2018.

07/03/2019

The company lodges ist Appendix 4D and Half-Year Financial Report.

07/03/2019

The company's securities will be suspended from official quotation following failure to lodge the relevant periodic report by the duee date.

01/03/2019

The suspension of trading in the securities of Manalto Limited will be lifted from the commencement of trading on Friday, 13 July 2018, following the release by the Company of an announcement regarding its activities.

12/07/2018

The company lodges its Quarterly Activities Report.

12/07/2018

The company lodges its Appendix 4C - quarterly.

12/07/2018

The company releases the results of its meeting.

04/07/2018

The company issues a prospectus for the offer of up to 500,000 Shares in the capital of the Company at an issue price of $0.001 per Share to raise up to $500 before expenses.

08/06/2018

3,953,949 options (exercisable at $0.20 on or before 29 February 2020) have lapsed in accordance with the terms and conditions of the Company's Employee Share and Option Plan as the holders have ceased employment with the Company. The Company also advises that in its announcement dated 11 October 2016, the number of options stated as lapsing in the class exercisable at $0.30 on or before 15 December 2020 was incorrectly overstated by 200,000.

08/06/2018

Notice is given that the meeting will be held at: 10:00am (WST) on 4 July 2018 at Central Park Theatrette 152-152 St Georges Terrace Perth WA 6000.

05/06/2018

The company has agreed to place a holding lock on all securities issued to the Blumenthal Parties and seek a new shareholder approval in relation to the issue of equity securities to the Blumenthal Parties on and from 15 September 2017 in accordance with ASX Listing Rule 10.11. A notice of meeting seeking this approval is currently being finalised and the shareholder meeting will be convened as soon as practicable.

25/05/2018

The company lodges a Quarterly Activities Report.

23/04/2018

The company lodges an Appendix 4C - quarterly.

23/04/2018

The company issues a response to ASX Query Letter.

12/04/2018

The company issues a prospectus for the offer of up to 500,000 Shares in the capital of the Company at an issue price of $0.001 per Share to raise up to $500 before expenses.

22/03/2018

Manalto has today issued 2,570,000,000 Shares to raise $2.57M pursuant to the placement approved at the AGM held 21 December 2017. This issue includes $0.97M of new funds in addition to the placement funds of $1.06M and $0.54M raised in the form of convertible loans. In addition, the Company has today issued 500M shares on conversion of convertible notes and 200M shares and 200M options to Advisors. Both issues were approved at the 2017 AGM. Following these issues, Manalto has 3,642,388,631 shares on issue. Manalto's current cash balance is $2.24M. Manalto advises that two option classes expired on 19 January 2018 and 11 March 2018 have expired unexercised. The exercise price was $0.07 and $0.25 respectively.

21/03/2018

Placement of funds of f $1,060,000 have been received, with securities to be issued shortly. This raise is in addition to the $540,000 raised in the form of convertible loans announced 20 December 2017 bringing the total amount raised to $1.6M. Manalto's current cash balance is $1.245M. Net of creditors, Manalto's net position is $1.165M which is sufficient to carry out the Company's objectives. Manalto has made the irrevocable decision to liquidate its Irish & Netherlands subsidiaries and cease funding these subsidiaries. In addition, Manalto has received an undertaking from EverBlu Capital that, in addition to the funds raised to date, EverBlu will use its best endeavours to raise additional placement funds utilising the placement capacity approved by shareholders at the AGM. EverBlu has indicated the raising of a further $1M in the next 60 days.

02/03/2018

The company lodges its Appendix 4D - Half Yearly Report.

01/03/2018

The company releases an Appendix 4G.

09/02/2018

The company lodges its Appendix 4C - quarterly report.

30/01/2018

The company releases the results of its meeting.

21/12/2017

The company provides an update on the following: its recent successes; completion of strategic review of the business and core product; simpler corporate structure - cost saving and improved efficiency; existing development pipeline; planned e-commerce integrations (blockchain); product development milestones since 15 September 2017; and a finance update. Manalto anticipates reinstatement to ASX quotation to commence on completion of the current placement.

20/12/2017

The company will hold its AGM at 10.00am WST on 21 December 2017 at Level 11, London House 216 St. Georges Terrace, PERTH WA 6000.

20/11/2017

The company lodges its Annual Report to shareholders.

30/10/2017

The company lodges its Appendix 4C - quarterly report.

30/10/2017

The remaining $550,000 from the chairman's list as disclosed to the market 23 August 2017 has now been received via the issue of convertible notes. Shares will be issued on conversion of these convertible notes in due course, at a conversion price of $0.011 per Share.

11/10/2017

The company issues a response to ASX query letter.

04/10/2017

The company issues a response to the ASX query letter.

27/09/2017

The securities of Manalto Limited will be suspended from quotation immediately pending clarification of the announcement made by the Company on 15 September 2017.

18/09/2017

The securities of Manalto Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

23/08/2017

The company completed a capital raising by way of placements of fully paid ordinary shares and commitments by way of convertible notes. All funds have now been received under Tranche 2 of the capital raising. All required shareholder approvals were received at the general meeting. The convertible notes will be converted to fully paid ordinary shares in due course.

23/08/2017

The company lodges its Appendix 4C - Quarterly Report.

23/08/2017

The company releases the results of its EGM.

04/08/2017

The securities of Manalto Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.

28/07/2017

The securities of Manalto Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

04/07/2017

Due to market conditions, the company has agreed to revised terms of the capital raising previously approved by shareholders at the EGM. The company now has successfgully raised $1,399,365 through the placement to professional, sophisticated and other exempt investors of 1,399,365 convertible notes. These Notes will convert to ordinary shares in the Company at a rate of 1.1 cents for each share with conversion rights subject to a shareholder approval being obtaining pursuant to the ASX Listing Rules.

04/07/2017

The securities of Manalto Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.

23/06/2017

The securities of Manalto Limited will be reinstated to quotation immediately, following the release of an announcement by the Company.

20/04/2017

The company has signed a binding terms sheet to acquire control of the assets of Bambu Digital. The acquisition will create a broad based software development house and distributer of business software product. A $2.5 million placement is being undertaken. A merger implementation plan is underway to unlock key synergies between the groups and go-to-market strategies.

20/04/2017

Manalto Limited advises that the following securities of the Company are due for release from escrow on 24 March 2017: 14,401,395 ordinary fully paid shares; 1,400,000 options expiring 15 December 2020 restricted exercisable at $0.25; and 4,550,000 options expiring 11 March 2020 restricted exercisable $0.25..

20/03/2017

The company lodges its Appendix 4D - Half Yearly Report.

28/02/2017

The securities of Manalto Limited will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company.

06/02/2017

The securities of Manalto Limited will be reinstated to quotation immediately, following the release of an announcement by the Company. Security Code: MTL

26/11/2015

Manalto Limited is pleased to announce that it has received commitments for a placement for approximately 44.2 million new fully paid ordinary shares at an issue price of $0.07 (7 cents) to raise $3.095 million. The Company also announces that it proposes making an offer to shareholders to apply for up to $15,000 of shares each at the same issue price as the Share Placement (7 cents per share), up to a total of approximately 27.2 million shares, to raise up to approximately $1.905 million.

26/11/2015

The securities of Manalto Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company. Security Code: MTL

20/11/2015

The securities of the Company will be reinstated to Official Quotation from the commencement of trading on Tuesday, 24 March 2015, following the Company's compliance with listing rule 11.1.3 and chapters 1 and 2 of the ASX Listing Rules

23/03/2015

name changed from Healthlinx Limited

18/03/2015

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments
As a HTX shareholder who now holds next to nothing, I only hope that this venture fails miserably and that the list of former Directors and Executives to the right are failing just as miserably.20/05/2015 11:14:18

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    11/07/2016Chris Adams40,000$0.050$2,000
    11/05/2015Trent Telford-80,000$0.288$23,040

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Colin MarlandManaging Director, CEO17/04/2020
    Justin VianelloCFO08/05/2015
    David MullanNon Exec Director29/10/2019
    Qi CaoNon Exec Director17/04/2020
    Timothy ChapmanDirector16/09/2014
    Richard RevelinsDirector21/03/2013
    Joseph MillerDirector11/03/2015
    Shanon ThomsonAdministrator02/08/2013
    David RossAdministrator02/09/2013

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Piers LewisNon Exec Chairman, Independent Director31/01/201917/04/2020
    Jason CollingNon Exec Director11/06/201917/04/2020
    Danny CostickNon Exec Director16/04/201927/11/2019
    Terence CleeExecutive Director15/09/201711/06/2019
    Tim WilsonNon Exec Director15/09/201716/04/2019
    James EllingfordDirector15/09/201731/01/2019
    Jim McKerlieExecutive Chairman28/10/201615/09/2017
    Paul GardnerNon Exec Director16/11/201615/09/2017
    Michael QuinertNon Exec Director06/09/201315/09/2017
    Gary CoxNon Exec Director16/11/201622/08/2017
    Chris AdamsChairman, Executive Director24/07/201502/06/2017
    Anthony OwenManaging Director11/03/201507/04/2017
    David FletcherNon Exec Chairman12/03/201511/04/2016
    Trent TelfordDirector21/03/201324/07/2015
    Mal Lucas-SmithNon Exec Director01/01/201306/09/2013
    Gregory RiceNon Exec Chairman17/02/200628/03/2013
    Nick GatsiosManaging Director17/02/200621/03/2013
    John EvansNon Exec Director01/04/200831/12/2012
    Stewart WasherNon Exec Director01/04/200813/06/2012
    John ChiplinNon Exec Director01/12/201013/06/2012

    Date of first appointment, title may have changed.